<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Biotechnology Industry News</title><link>http://biz.yahoo.com/ic/news/515.html</link><description>The latest news on the Biotechnology industry from Yahoo! Finance</description><language>en-us</language><lastBuildDate>Mon, 12 May 2008 02:34:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>[$$] BioMarin Takeover Talk Sparks Surge in Trading (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=11pl9bpoe/*http://online.wsj.com/article/SB121055875433384247.html?mod=yahoo_hs&amp;ru=yahoo</link><description>BioMarin Takeover Talk Sparks Surge in Trading Buyout rumors fueled much of the activity in options Friday, as market players took positions in several companies that surfaced as possible takeover targets.</description><guid isPermaLink="false">yahoo_finance/371016401</guid><pubDate>Mon, 12 May 2008 02:34:00 Etc/GMT</pubDate></item><item><title>[$$] Takeda Expects Profit To Fall This Year (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=11p50kje4/*http://online.wsj.com/article/SB121033353515280565.html?mod=yahoo_hs&amp;ru=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/3191735861</guid><pubDate>Mon, 12 May 2008 02:29:00 Etc/GMT</pubDate></item><item><title>[video] China Watch Mail Bag (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/video/ts/rss/SIG=125d9n4tc/*http://www.thestreet.com/_yahoo/video/strategysession/10416086.html?cm_ven=YAHOOV&amp;amp;cm_cat=FREE&amp;amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/1230368848</guid><pubDate>Sat, 10 May 2008 12:59:44 Etc/GMT</pubDate></item><item><title>Halozyme Therapeutics Inc. Q1 2008 Earnings Call Transcript (at Seeking Alpha)</title><link>http://us.rd.yahoo.com/finance/external/trsa/rss/SIG=132vkmege/*http://seekingalpha.com/article/76655-halozyme-therapeutics-inc-q1-2008-earnings-call-transcript?source=yahoo</link><description></description><guid isPermaLink="false">yahoo_finance/1237751625</guid><pubDate>Sat, 10 May 2008 00:02:08 Etc/GMT</pubDate></item><item><title>Bionovo reports $3.9 million loss in Q1 (at bizjournals.com)</title><link>http://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12i2kje7q/*http://sanfrancisco.bizjournals.com/sanfrancisco/stories/2008/05/05/daily52.html?ana=yfcpc</link><description></description><guid isPermaLink="false">yahoo_finance/895279610</guid><pubDate>Fri, 9 May 2008 22:05:08 Etc/GMT</pubDate></item><item><title>Repros Therapeutics&apos; 1Q loss widens on higher costs (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080509/earns_repros_therapeutics.html?.v=1</link><description>Biotechnology company Repros Therapeutics Inc. said Friday its first-quarter loss widened on higher spending for clinical development programs.</description><guid isPermaLink="false">yahoo_finance/1823583710</guid><pubDate>Fri, 9 May 2008 22:00:57 Etc/GMT</pubDate></item><item><title>Par Pharma 1Q earnings fall, but shares rise on adj. profit (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080509/earnings_par_pharmaceutical.html?.v=1</link><description>Shares of Par Pharmaceutical Cos. rose Friday even though the generic drug maker&apos;s profit fell nearly 94 percent, as adjusted profit beat Wall Street estimates and its 2008 earnings projection came within expectations.</description><guid isPermaLink="false">yahoo_finance/3526043112</guid><pubDate>Fri, 9 May 2008 21:44:20 Etc/GMT</pubDate></item><item><title>Repros Therapeutics Inc. Reports First Quarter 2008 Financial Results and Provides Clinical Development Program Overview (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080509/20080509005822.html?.v=1</link><description>THE WOODLANDS, Texas----Repros Therapeutics today announces financial results for the first quarter ended March 31, 2008 and provides a clinical development program overview.</description><guid isPermaLink="false">yahoo_finance/3398841614</guid><pubDate>Fri, 9 May 2008 21:23:00 Etc/GMT</pubDate></item><item><title>PDL BioPharma shares hit 5-year low on wider 1Q loss (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080509/pdl_biopharma_mover.html?.v=2</link><description>Shares of PDL BioPharma Inc. fell Friday, after the company said its first-quarter loss widened on discontinued operations related to the sale of several key drug assets.</description><guid isPermaLink="false">yahoo_finance/2406197814</guid><pubDate>Fri, 9 May 2008 21:10:14 Etc/GMT</pubDate></item><item><title>BioSante Pharmaceuticals Reports First Quarter 2008 Financial Results (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080509/20080509005798.html?.v=1</link><description>LINCOLNSHIRE, Ill.----BioSante Pharmaceuticals, Inc. today reported its March 31, 2008 financial results and cash balance for the first quarter ended March 31, 2008.</description><guid isPermaLink="false">yahoo_finance/650373294</guid><pubDate>Fri, 9 May 2008 21:00:00 Etc/GMT</pubDate></item><item><title>Progenics reports wider 1Q loss on higher research expenses (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080509/earns_progenics.html?.v=1</link><description>Biopharmaceutical company Progenics Pharmaceuticals Inc. Friday said that its first-quarter loss widened on higher research and development, as well as administrative costs.</description><guid isPermaLink="false">yahoo_finance/490103203</guid><pubDate>Fri, 9 May 2008 20:54:50 Etc/GMT</pubDate></item><item><title>Amgen spent $2.5M lobbying on biotech in the first quarter (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080509/amgen_lobbying.html?.v=1</link><description>Biotech drugmaker Amgen Inc. spent $2.5 million lobbying the federal government in the first quarter of 2008. Amgen lobbied on legislation that would allow the Food and Drug Administration to approve generic copies of biotech drugs.</description><guid isPermaLink="false">yahoo_finance/1599477758</guid><pubDate>Fri, 9 May 2008 20:40:30 Etc/GMT</pubDate></item><item><title>Closing Glance: Biotechnology (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/080509/closing_glance_biotechnology.html?.v=1</link><description>Shares of biotechnology companies closed mixed Friday as the broader market tumbled over wider-than-expected losses at insurer American International Group Inc. and a spike in oil prices.</description><guid isPermaLink="false">yahoo_finance/3888822540</guid><pubDate>Fri, 9 May 2008 20:39:57 Etc/GMT</pubDate></item><item><title>Bionovo Reports First Quarter 2008 Financial Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080509/aqf075.html?.v=27</link><description>Bionovo, Inc. today announced results for the first quarter of 2008.</description><guid isPermaLink="false">yahoo_finance/1369622593</guid><pubDate>Fri, 9 May 2008 20:30:00 Etc/GMT</pubDate></item><item><title>Genaera Corporation Announces First Quarter Financial Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080509/nyf005a.html?.v=4</link><description>Genaera Corporation today announced its financial results for the quarter ended March 31, 2008. The net loss for the quarter ended March 31, 2008 was $4.3 million, or $ per basic and diluted share, as compared to a net loss of $4.2 million, or $ per basic and diluted share, for the quarter ended March 31, 2007.</description><guid isPermaLink="false">yahoo_finance/1042620863</guid><pubDate>Fri, 9 May 2008 20:20:00 Etc/GMT</pubDate></item><item><title>Gilead Sciences to Present at the Bank of America 2008 Healthcare Conference on Tuesday, May 13 (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080509/20080509005644.html?.v=1</link><description>FOSTER CITY, Calif.----Gilead Sciences, Inc. today announced that its corporate presentation will be webcast from the Bank of America 2008 Healthcare Conference in Las Vegas. This webcast may be accessed via the company&apos;s corporate website at www.gilead.com.</description><guid isPermaLink="false">yahoo_finance/1420049336</guid><pubDate>Fri, 9 May 2008 20:15:00 Etc/GMT</pubDate></item><item><title>Cardium Reports on First Quarter 2008 Highlights and Financial Results (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080509/laf520.html?.v=3</link><description>Cardium Therapeutics today reported recent highlights and developments, as well as financial results for its first quarter ended March 31, 2008.</description><guid isPermaLink="false">yahoo_finance/1937181779</guid><pubDate>Fri, 9 May 2008 20:15:00 Etc/GMT</pubDate></item><item><title>Biotech Earnings Review: Celgene, Biogen (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=124m6f0kg/*http://www.thestreet.com/_yahoo/newsanalysis/biotech/10416103.html?cm_ven=YAHOO&amp;amp;cm_cat=FREE&amp;amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/749064199</guid><pubDate>Fri, 9 May 2008 19:51:07 Etc/GMT</pubDate></item><item><title>Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080509/nef057a.html?.v=1</link><description>Alseres Pharmaceuticals, Inc. , today announced that they will host a conference call on Thursday, May 15th, 2008 at 9:00am EDT to review the first quarter ending March 31, 2008 and discuss other matters related to the Company.</description><guid isPermaLink="false">yahoo_finance/878154137</guid><pubDate>Fri, 9 May 2008 19:00:00 Etc/GMT</pubDate></item><item><title>Cyclacel Pharmaceuticals Announces First Quarter 2008 Financial Results (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/080509/20080509005712.html?.v=1</link><description>BERKELEY HEIGHTS, N.J.----Cyclacel Pharmaceuticals, Inc. announced today financial and operating results for the first quarter of 2008. The Company&apos;s net loss for the quarter was $6.3 million or $0.31 per share.</description><guid isPermaLink="false">yahoo_finance/386834800</guid><pubDate>Fri, 9 May 2008 19:00:00 Etc/GMT</pubDate></item></channel></rss><!-- c38.finance.mud.yahoo.com uncompressed/chunked Sun May 11 21:27:24 PDT 2008 -->
